8-K - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)
Published . Updated .
8-K - Arcutis Biotherapeutics filed an 8-K with the SEC on Oct 28 (a notice of a material company event).
Directly affected
- ARQT Arcutis Biotherapeutics+21.1% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Arcutis Biotherapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+12.6% 30d
Eli Lilly and is a peer of Arcutis Biotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+0.5% 30d
Johnson & Johnson is a peer of Arcutis Biotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+9.1% 30d
AbbVie is a peer of Arcutis Biotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck-2.1% 15d
Merck is a peer of Arcutis Biotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories-2.0% 30d
Abbott Laboratories is a peer of Arcutis Biotherapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ARQT | +0.66% | -1.48% | base | +0.33% | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-28 AccNo: 0001628280-26-067752 Size: 1 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD…
Source: sec-edgar
How far Arcutis Biotherapeutics (ARQT) has moved since 28 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | that day | +0.33% | still updating |
| Arcutis Biotherapeutics (ARQT) | three days earlier | -1.48% | final price |
| Arcutis Biotherapeutics (ARQT) | five days earlier | +0.66% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 50 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 44 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 70 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 40 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Arcutis Biotherapeutics (ARQT)
Companies carried with this story
- ARQT Arcutis Biotherapeutics
For “8-K - Arcutis Biotherapeutics, Inc. (0001787306) (Filer),” Arcutis Biotherapeutics (ARQT) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ARQT
How “8-K - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)” reaches Arcutis Biotherapeutics (ARQT)
“8-K - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)” (28 Oct 2026) reaches Arcutis Biotherapeutics (ARQT) through this story.
For Arcutis Biotherapeutics (ARQT), the reason on file says SEC 8-K filing -> direct issuer disclosure -> ARQT
Dates and price levels for Arcutis Biotherapeutics (ARQT)
ARQT traded between 23.10 and 29.45 across 20 sessions. The latest close on file is 28.85.
How strong the case is around Arcutis Biotherapeutics (ARQT)
14 out of 100Price not final
“8-K - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies. The price is not final yet.